Correction to. CDK4/6 inhibitors downregulate the ubiquitin-conjugating enzymes UBE2C/S/T involved in the ubiquitin–proteasome pathway in ER + breast cancer

• Chih-Yi Lin ^[2] ; Chung-Jen Yu ^[2] ; Chun-Yu Liu ^[3] ; Ta-Chung Chao ^[3] ; Chi-Cheng Huang ^[1] ; Ling-Ming Tseng ^[3] ; Jiun-I. Lai ^[2]
  1. [1] Taipei Veterans General Hospital

     Taipei Veterans General Hospital

     Taiwán

     
  2. [2] Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan
  3. [3] School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan

  Mostrar afiliaciones +
• Localización: Clinical & translational oncology, ISSN 1699-048X, Vol. 24, Nº. 11 (November), 2022, págs. 2251-2253
• Idioma: inglés
• Texto completo no disponible (Saber más ...)